Pradžia › Širdies priepuolis › New Jersey
Širdies priepuolis klinikiniai tyrimai New Jersey
5 tyrimai dėl Širdies priepuolis ieško dalyvių vietose New Jersey.
Oficialus tyrimo tekstas (anglų kalba)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Hypertension & Nephrology Association, Eatontown
- New Jersey Kidney Care, Jersey City
Renkami dalyviai2/3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-21 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- The Valley Hospital, Ridgewood
- Overlook Medical Center, Summit
Renkami dalyviai3 fazė
Amžius nuo 18 iki 100 · Visoms lytims · Atnaujinta 2026-09-04 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Advanced Heart Care LLC, Bridgewater
- Advanced Heart and Vascular Institute of Hunterdon, Flemington
- Clinical Reseach Philadelphia Pennington, Hamilton
- ir dar 7
Renkami dalyviai3 fazė
Amžius nuo 50 iki 105 · Visoms lytims · Atnaujinta 2026-08-21 · NCT07136012AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Hackensack University Medical Center, Hackensack
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-01 · NCT06699056Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Rutgers University, Newark
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-03-24 · NCT04774159Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.